Annual Cash & Cash Equivalents
$1.17 M
-$3.22 M-73.29%
December 31, 2023
Summary
- As of February 26, 2025, RNXT annual cash & cash equivalents is $1.17 million, with the most recent change of -$3.22 million (-73.29%) on December 31, 2023.
- During the last 3 years, RNXT annual cash & cash equivalents has fallen by -$622.00 thousand (-34.65%).
- RNXT annual cash & cash equivalents is now -92.28% below its all-time high of $15.19 million, reached on December 31, 2021.
Performance
RNXT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$9.56 M
-$2.18 M-18.56%
September 30, 2024
Summary
- As of February 26, 2025, RNXT quarterly cash and cash equivalents is $9.56 million, with the most recent change of -$2.18 million (-18.56%) on September 30, 2024.
- Over the past year, RNXT quarterly cash and cash equivalents has dropped by -$2.18 million (-18.56%).
- RNXT quarterly cash and cash equivalents is now -46.05% below its all-time high of $17.73 million, reached on September 30, 2021.
Performance
RNXT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RNXT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -73.3% | -18.6% |
| 3 y3 years | -34.6% | -18.6% |
| 5 y5 years | -44.3% | -18.6% |
RNXT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.3% | at low | -37.0% | +715.3% |
| 5 y | 5-year | -92.3% | at low | -46.0% | +1042.5% |
| alltime | all time | -92.3% | at low | -46.0% | +1042.5% |
RenovoRx Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.56 M(-18.6%) |
| Jun 2024 | - | $11.74 M(+167.5%) |
| Mar 2024 | - | $4.39 M(+274.2%) |
| Dec 2023 | $1.17 M(-73.3%) | $1.17 M(-63.6%) |
| Sep 2023 | - | $3.23 M(-45.8%) |
| Jun 2023 | - | $5.95 M(+59.9%) |
| Mar 2023 | - | $3.72 M(-15.2%) |
| Dec 2022 | $4.39 M | $4.39 M(+42.0%) |
| Sep 2022 | - | $3.09 M(+11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $2.77 M(-78.9%) |
| Mar 2022 | - | $13.12 M(-13.6%) |
| Dec 2021 | $15.19 M(+746.4%) | $15.19 M(-14.3%) |
| Sep 2021 | - | $17.73 M(+1038.4%) |
| Jun 2021 | - | $1.56 M(+86.0%) |
| Mar 2021 | - | $837.00 K(-53.4%) |
| Dec 2020 | $1.79 M(-14.7%) | - |
| Dec 2020 | - | $1.79 M |
| Dec 2019 | $2.10 M | - |
FAQ
- What is RenovoRx annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for RenovoRx?
- What is RenovoRx annual cash & cash equivalents year-on-year change?
- What is RenovoRx quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for RenovoRx?
- What is RenovoRx quarterly cash and cash equivalents year-on-year change?
What is RenovoRx annual cash & cash equivalents?
The current annual cash & cash equivalents of RNXT is $1.17 M
What is the all time high annual cash & cash equivalents for RenovoRx?
RenovoRx all-time high annual cash & cash equivalents is $15.19 M
What is RenovoRx annual cash & cash equivalents year-on-year change?
Over the past year, RNXT annual cash & cash equivalents has changed by -$3.22 M (-73.29%)
What is RenovoRx quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RNXT is $9.56 M
What is the all time high quarterly cash and cash equivalents for RenovoRx?
RenovoRx all-time high quarterly cash and cash equivalents is $17.73 M
What is RenovoRx quarterly cash and cash equivalents year-on-year change?
Over the past year, RNXT quarterly cash and cash equivalents has changed by -$2.18 M (-18.56%)